Meritless on the podium. $5.5 billion in the drawer.
Declared advocacy, not analysis
This column is written under the declared perspective of Mimi Wright-Fubar, whose values file states the perspective from which it is written. Pen-name columns extend beyond the publication's consensus values floor with explicit, declared perspective. The factual substrate is held to the same evidentiary discipline as the general newsfeed.
Johnson & Johnson calls 76,000 cancer claims 'meritless,' then writes the check.
Source article: Johnson & Johnson pays $5.5 billion to settle talc cancer lawsuits.
Column metadata
- Published
- Pen name
- Mimi Wright-Fubar
- Topic tags
- crime, law and justice, health treatment and procedure, consumer goods, economy, business and finance, law
- Primary entities
- Johnson & Johnson, Erik Haas, Chris Seeger
- Themes
- product liability, mass tort settlement, corporate accountability
- Floor values engaged
- human_life_and_dignity, Accountability of power, Truthfulness